In summary, our data is consistent with previous reports that elevated PIM2 and PIM3 were responsible for TKI-resistance by protecting blasts against spontaneous apoptosis through phosphorylating BAD, leading to the poor survival of AML patients (31, 32). This evidence concerns the gene PIM2 and acute myeloid leukemia.